India’s Biocon secures approval to use drug on Covid-19 patients
India's Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday. The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in
সম্পূর্ণ আর্টিকেলটি পড়ুন
We use cookies to ensure you get the best experience on our website.